NextCure Statistics Share Statistics NextCure has 2.68M
shares outstanding. The number of shares has increased by 15.12%
in one year.
Shares Outstanding 2.68M Shares Change (YoY) 15.12% Shares Change (QoQ) 14.94% Owned by Institutions (%) 36.8% Shares Floating 1.88M Failed to Deliver (FTD) Shares 1,415 FTD / Avg. Volume 1.25%
Short Selling Information The latest short interest is 31.41K, so 1.17% of the outstanding
shares have been sold short.
Short Interest 31.41K Short % of Shares Out 1.17% Short % of Float 1.19% Short Ratio (days to cover) 2.64
Valuation Ratios The PE ratio is -0.39 and the forward
PE ratio is -0.48.
NextCure's PEG ratio is
0.03.
PE Ratio -0.39 Forward PE -0.48 PS Ratio 0 Forward PS 4.7 PB Ratio 0.33 P/FCF Ratio -0.52 PEG Ratio 0.03
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for NextCure.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 7.5,
with a Debt / Equity ratio of 0.09.
Current Ratio 7.5 Quick Ratio 7.5 Debt / Equity 0.09 Debt / EBITDA -0.11 Debt / FCF -0.14 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.29M Employee Count 43 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -64.01% in the
last 52 weeks. The beta is 1.34, so NextCure's
price volatility has been higher than the market average.
Beta 1.34 52-Week Price Change -64.01% 50-Day Moving Average 5.3 200-Day Moving Average 6.66 Relative Strength Index (RSI) 61.75 Average Volume (20 Days) 112,901
Income Statement
Revenue n/a Gross Profit -2.87M Operating Income -59.75M Net Income -55.65M EBITDA -54.34M EBIT -57.21M Earnings Per Share (EPS) -23.88
Full Income Statement Balance Sheet The company has 27.73M in cash and 5.95M in
debt, giving a net cash position of 21.78M.
Cash & Cash Equivalents 27.73M Total Debt 5.95M Net Cash 21.78M Retained Earnings -380.14M Total Assets 47.69M Working Capital 29.23M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -40.8M
and capital expenditures -474K, giving a free cash flow of -41.28M.
Operating Cash Flow -40.8M Capital Expenditures -474K Free Cash Flow -41.28M FCF Per Share -17.71
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields NXTC does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for NXTC is $25.5,
which is 337.4% higher than the current price. The consensus rating is "Buy".
Price Target $25.5 Price Target Difference 337.4% Analyst Consensus Buy Analyst Count 2
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Jul 14, 2025. It was a
backward
split with a ratio of 1:12.
Last Split Date Jul 14, 2025 Split Type backward Split Ratio 1:12
Scores Altman Z-Score -15.33 Piotroski F-Score 1
